芝商所(CME Group)

US · CME #222 按市值排名上市于 2002

293.87 +4.41 +1.52%

实时 - 追踪5344个代码 - 心跳于62秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了16家。
机构持股总比例下降了0.3个百分点。

机构持股

机构持股比例: 91.88% -0.31pp
机构数量: 2,002 -16
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund72.46%

Public Company6.53%

Hedge Fund5.56%

Private Company2.73%

Government Pension Fund2.09%

Sovereign Wealth Fund1.40%

Family Office/Trust0.36%

Insurance Company0.30%

Individual/Insider0.29%

Other8.27%

主要股东截至 2026-06-30

BlackRock 8.50% · 30.57M 股

Vanguard Capital Management, LLC 7.15% · 25.70M 股

State Street Global Advisors 4.55% · 16.35M 股

Capital Research 3.11% · 11.18M 股

Geode Capital Management, LLC 2.58% · 9.27M 股

Other 74.12%

Vanguard Portfolio Management, LLC 2.55% · 9.17M 股

Sanders Capital, LLC 1.41% · 5.07M 股

Morgan Stanley 1.34% · 4.82M 股

Norges Bank Investment Management 1.34% · 4.82M 股

UBS Asset Management 1.27% · 4.57M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 32次买入 · 17次卖出

姓名	职务	持股比例
William Shepard	Independent Director	0.07%
William Hobert	Independent Director	0.04%
Howard Siegel	Independent Director	0.02%
Terrence Duffy	Chairperson & CEO	0.02%
Patrick Mulchrone	Independent Director	0.02%
Bryan Durkin	Director	0.01%
Larry Gerdes	Independent Director	0.01%
Derek Sammann	Senior MD and Global Head of Commodities, Options Products & International Markets	0.01%
Julie Winkler	Senior MD & Chief Commercial Officer	0.01%
Hilda Piell	Senior MD & Chief Human Resources Officer	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-24	William Shepard	Independent Director	Open Market Acquisition	+292	$268.76
2026-09-15	Kendal Vroman	Chief Transformation Officer	Sale to Issuer	-1,211	$272.46–275.09
2026-09-15	Derek Sammann	Senior MD and Global Head of Commodities, Options Products & International Markets	Sale to Issuer	-1,413	$272.46–275.09
2026-09-15	Sunil Cutinho	Chief Information Officer	Sale to Issuer	-1,413	$272.46–275.09
2026-09-15	Julie Winkler	Senior MD & Chief Commercial Officer	Sale to Issuer	-1,413	$272.46–275.09
2026-09-15	Jack Tobin	MD & Chief Accounting Officer	Sale to Issuer	-347	$272.46–275.09
2026-09-15	Tim McCourt	Senior MD and Global Head of Financial & OTC Products	Sale to Issuer	-1,334	$272.46–275.09
2026-09-15	John Marchese	MD & Associate General Counsel of Litigation & Information Technology	Sale to Issuer	-241	$272.46–275.09
2026-09-15	Michael Dennis	Director	Sale to Issuer	-548	$272.46–275.09
2026-09-15	Suzanne Sprague	Senior MD and Global Head of Clearing & Post-Trade Services	Sale to Issuer	-1,152	$272.46–275.09
2026-09-15	Lynne Fitzpatrick	Chief Financial Officer	Sale to Issuer	-1,340	$272.46–275.09
2026-09-14	Terrence Duffy	Chairperson & CEO	Other Acquisition	+21,812	$275.09
2026-09-14	Kendal Vroman	Chief Transformation Officer	Other Acquisition	+2,592	$275.09
2026-09-14	Derek Sammann	Senior MD and Global Head of Commodities, Options Products & International Markets	Other Acquisition	+7,493	$275.09
2026-09-14	Sunil Cutinho	Chief Information Officer	Other Acquisition	+2,864	$275.09
2026-09-14	Julie Winkler	Senior MD & Chief Commercial Officer	Other Acquisition	+2,864	$275.09
2026-09-14	Jack Tobin	MD & Chief Accounting Officer	Other Acquisition	+700	$275.09
2026-09-14	Tim McCourt	Senior MD and Global Head of Financial & OTC Products	Other Acquisition	+2,592	$275.09
2026-09-14	John Marchese	MD & Associate General Counsel of Litigation & Information Technology	Other Acquisition	+784	$275.09
2026-09-14	Michael Dennis	Director	Other Acquisition	+2,592	$275.09

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。